Boehringer Ingelheim reached a sales figure of €24.1 billion in 2022, which translates into a year-on-year rise of 10.5%. In 2022, the Spanish subsidiary registered an...
Prim aims to achieve sales of €305 million by 2025. The company founded in 1870 expects that by that date 25% of its business will come...
Galenicum Axium, a subsidiary that focuses on the development of licenses and distribution of medicines for other companies and is one of the company's main sources...
Oniria Therapeutics is a company dedicated to the development of precision drugs in the preclinical stage focused on the elimination of persistent tumor cells, which are...
In 2022, the company's results stood at €15.6 million, which translates into a rise of 47.2% compared to the previous year. However, in the same period,...
Vitro works mainly with public health, which represents between 80% and 85% of its business, and with large private chains. The biotech company has grown to...
In 2022, Durcal reached an average sale of 500 telecare watches per month, with peaks of up to a thousand monthly sales. Now, the company will...
The European pharmaceutical sector is on the rise. EU pharmaceutical exports were led by Germany and Belgium. By contrast, the largest importers were Belgium (€21 billion), followed...
Amelia Virtual Care offers virtual reality software for mental health professionals with more than 140 virtual environments, providing clinicians with access to exposure tools and systematic...
Chiesi Global Rare Diseases is a business unit of the Chiesi Pharmaceuticals Group established to offer innovative therapies and solutions to people with rare diseases. Its...